Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real-world experience from a tertiary cancer center

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real-world experience from a tertiary cancer center

Introduction: Checkpoint inhibitors (CPIs) are rapidly becoming the standard of care in solid tumors for multiple indications. Steroids due to their immunosuppressive nature might decrease the efficacy of these agents. To test this hypothesis, we performed an audit of our patients who had received C...

Full description

Bibliographic Details
Main Authors: Akhil Kapoor, Vanita Noronha, Vijay M Patil, Amit Joshi, Nandini Menon, George Abraham, Vikas Talreja, Hollis D′Souza, Kumar Prabhash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
antibiotics
checkpoint inhibitors
steroids
survival outcomes
immunotherapy
ici
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=2;spage=204;epage=208;aulast=Kapoor

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=2;spage=204;epage=208;aulast=Kapoor

Similar Items